CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference
CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
View All Press
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.
Continue